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Available online 4 December 2013Abstract Many studies have compared the genetic and epigenetic profiles of human induced pluripotent stem cells (hiPSCs) to
human embryonic stem cells (hESCs) and yet the picture remains unclear. To address this, we derived a population of neural precursor
cells (NPCs) from the H1 (WA01) hESC line and generated isogenic iPSC lines by reprogramming. The gene expression and methylation
profile of three lines were compared to the parental line and intermediate NPC population. We found no gene probe with expression
that differed significantly between hESC and iPSC samples under undifferentiated or differentiated conditions. Analysis of the global
methylation pattern also showed no significant difference between the two PSC populations. Both undifferentiated populations were
distinctly different from the intermediate NPC population in both gene expression and methylation profiles. One point to note is that
H1 is a male line and so extrapolation to female lines should be cautioned. However, these data confirm our previous findings that
there are no significant differences between hESCs and hiPSCs at the gene expression or methylation level.
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Human induced pluripotent stem cells (hiPSCs) share key
features and potential of human embryonic stem cells (hESCs)
and allow the generation of patient-specific material (Ebert
et al., 2009; Soldner et al., 2009). However, the extent to
which they faithfully recapitulate the characteristics of
embryonic stem cells remains a subject of debate (Feng et
al., 2010; Hu et al., 2010; Smith et al., 2009). There have beener B.V. All rights reserved.
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and methylation profiles of ESCs and iPSCs (Bock et al., 2011;
Chin et al., 2009; Lister et al., 2011; Mallon et al., 2013) and a
number of studies have shown evidence that generation of
iPSCs can induce abnormalities at both genetic and epigenetic
levels (Gore et al., 2011; Hussein et al., 2011; Laurent et al.,
2011; Lister et al., 2011; Mayshar et al., 2010). In addition,
there has been much made of ‘epigenetic memory’ in which
induced pluripotent cells are said to retain some epigenetic
marks of the donor cell type from which they were derived
(Kim et al., 2010; Marchetto et al., 2009).
Previously, we reported that there were no significant
gene expression differences between 21 hESCs and 8 hiPSCs
(Mallon et al., 2013) in accordance with other findings
(Guenther et al., 2010). In that study, we found that,
although some genes were variably expressed, there were
no genes that were significantly increased in one popula-
tion over the other. Although some studies have described
differences in the methylation profile between hESCs and
hiPSCs (Bock et al., 2011; Deng et al., 2009; Doi et al.,
2009; Kim et al., 2010; Lister et al., 2009), this may simply
reflect normal human variation (Lo et al., 2003; Yan et al.,
2002) or may actually be a result of the reprogramming
process. To address this, Teichroeb et al., compared the
genetic profile of H9 (WA09) hESCs to a clonally purified
mortal splanchnopleuric mesodermal somatic cell line
differentiated from them, EN13, and hiPSCs derived from
these differentiated cells (Teichroeb et al., 2011). In this
female line, they found the gene expression profiles to be
generally very similar with the only striking difference in
gene expression being that of neuronatin (NNAT), amaternally
silenced imprinted gene. This, together with their observation
of hotspots of de-repression of X chromosome inactivation
(XCI), led them to conclude that reprogramming affects both
imprinting and XCI. However, a recent review of this phenom-
enon indicated that much of this genetic and epigenetic drift
may be caused by local culture conditions (Wutz, 2012).
To complement and extend the previous study, we have
used a well known male hESC line, H1 (WA01), to investigate
the gene expression and methylation profiles of isogenic
hESCs and hiPSCs. We derived an intermediate neural stem
cell precursor cell (NPC) line from these hESCs (Kozhich et al.,
2012) and expanded it several times before reprogramming to
induced pluripotent stem cells using lentiviral transduction of
the 4 Yamanaka factors (Oct4, KLF4, SOX2 and c-myc). Several
independent colonies were expanded and analyzed for gene
expression and methylation using array-based analyses as
described previously (Mallon et al., 2013). Although the iPSC
lines derived vary slightly at the genomic level due to lentiviral
integration, in accordance with the previous study (Teichroeb
et al., 2011), these lines are referred to in this manuscript as
isogenic reflecting the overall similarities between them
and the parental H1 line. No significant difference in gene
expression was found between the pluripotent cell popula-
tions under undifferentiated or differentiated conditions.
Similarly, little variation was observed in the methylation
profile of the undifferentiated cells although some deviation
was observed between the pluripotent populations and the
NPCs as would be expected following differentiation. Exam-
ination of the gene expression of putative imprinted genes
showed variability in expression for many of them, often in
response to differentiation. However, no genes were expressedat significantly different levels in the isogenic hiPSC population
relative to the H1 parental line. We more closely examined
NNAT expression in the StemCellDB database and found that
gene expression was variable in both hESC and hiPSC popula-
tions and appeared to be regulated by methylation. Interest-
ingly, the hiPSCs appeared to be more sensitive to
down-regulation by increased methylation. However, this
phenomenon was not apparent in the current H1 isogenic
study. All microarray and methylation array data may be
accessed through the NCBI GEO public database (Superseries
number GSE51748).
Experimental procedures
Feeder-based pluripotent stem cell culture
All culture reagents were acquired from Life Technologies
unless stated otherwise. Standard culture conditions of 37 °C,
5% CO2 and 95% humidity were maintained for all cells.
Human pluripotent stem cells (hPSCs) were cultured on
a feeder-layer of irradiated CF1 mouse embryonic fibro-
blasts (MEFs) in DMEM:F12 (Cat# 11330-032) containing 20%
Knockout Serum Replacement (KSR), 1 mM glutamine, 0.1 mM
β-mercaptoethanol (β-ME; Sigma), 1× non-essential amino
acids (NEAA) and 4 ng/ml bFGF (R&D Systems). Fibroblasts
were cultured in DMEM (Cat# 11965-092) containing 10% fetal
bovine serum (FBS) (Gemini Bio-products), 2 mM glutamine and
1× NEAA. Fibroblasts were irradiated with ~6500 rads using a
Faxitron RX650 X-irradiator. They were subsequently plated on
Falcon 6-well tissue culture dishes, coated with 0.1% gelatin, at
a density of 0.1875 × 106/well. hPSCs were plated in small
clumps of approximately 100 cells the following day, medium
was exchanged every day and colonies were passaged by
collagenase treatment every 3–4 days. Briefly, cultures were
treated with 1.5 mg/ml collagenase IV for 20–40 min and
either tapped sharply or scraped to dislodge colonies. Colonies
were allowed to sediment for 5 min, the supernatant was
removed and fresh media added. This process was repeated for
a total of 3 sediments. At this point cells were triturated to
generate colonies of approximately 10–100 cells for passaging.
Derivation of neural precursor cells (NPCs) from H1
(WA01) human embryonic stem cells
A proliferating population of neuronal precursor cells (NPCs)
were derived from the H1 (WA01) human embryonic stem
cell line as previously described (Kozhich et al., 2012). Briefly,
embryoid bodies (EBs) were cultured in DMEM containing
B27 minus Vitamin A and 2 mM L-glutamine, (Neural Precursor
Medium; NPM) supplemented with 500 ng/ml noggin (R&D
Systems) and 20 ng/ml bFGF (R&D Systems) for 2 weeks. At
this time the EBs were plated out in a minimal medium
consisting of DMEM containing an Insulin–Transferrin–Selenium
supplement (Life Technologies), 2 mM L-glutamine and
5 ng/ml human fibronectin (Roche) for 1 week. Migrating
neuroepithelial cells were isolated by Accutase (Innovative
Technologies Inc.) treatment and differential sedimenta-
tion to remove the larger aggregates. These NPCs were
propagated on polyOrnithine/laminin (both Sigma) coated
plates in NPM supplemented with 20 ng/ml each of bFGF
and EGF (R&D Systems).
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A slight modification of the manufacturer's instructions for
the StemCCA kit (Millipore) was followed. Briefly, approxi-
mately 40,000 NPCs were plated overnight in a 48-well plate
coated with poly-L-ornithine and laminin. An amount of virus
appropriate to give a MOI of 200 was added to one well of
H1.NPCs along with 5 μg/ml polybrene in NPM containing
bFGF and EGF. The next day, cells were washed once with
Dulbecco's phosphate buffered saline (D-PBS) and the
transduction was repeated. Cells were washed three times
with D-PBS and NPM containing bFGF and EGF as well as
chemicals 5 μM PS48 (Reagents Direct), 0.5 μM A-83-01
(StemGent) and 0.25 mM sodium butyrate (StemGent) to
enhance reprogramming (Zhu et al., 2010), was added. After
6 days of culture, the cells were dissociated with Accutase
and replated on 1 well of MEFs in NPM containing bFGF and
EGF. The day after plating the medium was switched to hESC
culture medium containing the reprogramming cocktail and
cells were fed daily with this medium until colonies started
to appear. At that time reprogramming chemicals were
omitted and cells were fed with standard hESC medium.
After approximately 3 weeks, visible iPSC colonies were
individually isolated and expanded. The remaining colonies
on the well were passaged with collagenase and replated on
Matrigel in mTeSR1 as described below.
Feeder-free pluripotent stem cell culture
To coat 6-well plates with Matrigel, 1.5 ml of 1.25% Matrigel
in DMEM:F12 was added to each well and incubated at 4 °C
overnight. The plate was allowed to warm to room temper-
ature prior to plating small clumps as described above in
mTeSR1 medium (Stem Cell Technologies). Colonies were
maintained in mTeSR1 medium and passaged as described for
feeder-based culture except for the use of 1 mg/ml dispase
instead of collagenase IV.
EB formation
Embryoid bodies were formed by culturing detached colonies
in fibroblast medium (EB_mesend) or in hESC medium without
bFGF (EB_ecto) in 60 mmCorning Low Attachment dishes for a
total of 8 days. Media were changed by sedimentation every
2 days.
FACS analysis
After collection of the colonies by collagenase or dispase
treatment as described above, cells were washed once with
Dulbecco's phosphate buffered saline (D-PBS) and treated
with Accutase for 10 min at 37 °C. Cells were washed with
5 ml DMEM:F12, centrifuged at 200 g for 5 min and resuspended
in FACS buffer (10% FBS in DMEM:F12) and maintained on ice.
Antibodies, including IgM isotype control (Sigma), were diluted
to twice the final concentration listed below and 50 μl of each
dispensed into a well of a round-bottom 96-well plate (Fisher
Scientific). To this was added 50 μl of cell suspension containing
approximately 10–25 × 104 cells. Antibodies used were SSEA4
(1:100; Santa Cruz sc-21704), Tra-1-60 (1:100; Santa Cruz
sc-21705) and NCAM (1:250; Millipore Corp MAB5324). Cellswere incubated for 1 h at 4 °C, washed with FACS buffer and
incubated with 1:100 AlexaFluor 488-conjugated anti-IgM (Life
Technologies) for 30 min at 4 °C. Cells were again washed with
FACS buffer and resuspended in approximately 125 μl FACS
buffer prior to FACS analysis using a Becton Dickenson
FACSCalibur with a 96-well plate HTS attachment. Data was
collected and analyzed using Plate Manager and CellQuest Pro
software (BD).
Negative magnetic sorting
Cells were subjected to negative magnetic sorting using Tra-
1-60 antibody and IgM conjugated magnetic beads (Miltenyi
Biotech) according to the manufacturer's instructions.
Immunostaining
Cells were fixed by rinsing briefly with D-PBS followed by
20 min incubation with 4% paraformaldehyde in PBS (Elec-
tron Microscopy Sciences) at room temperature. Cells were
blocked and permeabilized by incubation for 40 min in 10%
normal goat serum (NGS; Sigma) containing 0.3% Triton
X-100 (Sigma) in D-PBS. Appropriate dilutions of primary
antibodies were made in 5% NGS in D-PBS and applied to cells
after 3 washes in D-PBS (1:500 Oct3/4, Santa Cruz sc-5279;
1:5000 albumin, Cedarlane CL2513A; 1:100 AFP, Santa Cruz
sc-8399; 1:100 HNF4A, Cell Signaling Technologies 3113S;
1:1000 TuJ1, Covance MMS-435P; 1:100 nestin, Millipore
MAB5326; 1:200 MAP-2, Sigma M1406; 1:40 Myosin Heavy
Chain β, MAB1548; 1:200 Troponin T, Lab Vision Corporation
MS-295-PO). After 3 h incubation at RT, cells were washed
and incubated with 1:1000 dilutions of appropriate
AlexaFluor-conjugated secondary antibodies in 5% NGS
in D-PBS (Life Technologies). Cells were incubated with
secondary antibodies for 1 h, washed 3 times in D-PBS and
incubated with 20 ng/ml bis-benzimide (Hoechst dye,
Sigma Cat# B-1155) for 20 min. After washing, cells were
mounted using AquaPolymount (Fisher) and imaged using a
Retiga camera, Zeiss Axiovert 200 inverted fluorescent
microscope and QCapture/Photoshop software.
Directed differentiation to endoderm and mesoderm
Cells were directed toward an endodermal (hepatocyte) fate
using a slight modification of the method of Si-Tayeb et al.
(Si-Tayeb et al., 2010). Briefly, pluripotent stem cells were
cultured on Matrigel for 3 days in mTeSR1 medium before
switching the medium to RPMI (Mediatech) supplemented
with B27 (Life Technologies) and 100 ng/ml Activin A (R&D
Systems). After 5 days the medium was switched to RPMI
supplemented with B27, 20 ng/ml BMP-4 and 10 ng/ml bFGF
(R&D Systems). Five days later the medium was again
switched to RPMI supplemented with B27 and 20 ng/ml
HGF (R&D Systems). In the original paper (Si-Tayeb et al.,
2010) these 2 steps were performed at hypoxic (4%) oxygen
concentrations but were performed here at normoxic
concentrations (20%). After a further five days the medium
was again switched to Hepatocyte Culture Medium (Lonza)
supplemented with 20 ng/ml oncostatin M (Millipore Corp).
Cells were incubated for 5 days prior to fixation. During each
stage the medium was exchanged once.
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fate using a slight modification of a protocol by He et al.
(He et al., 2003). Colonies of pluripotent cells, cultured on
Matrigel in mTeSR1, were used to form EBs in alpha-MEM
(Life Technologies) containing 2 mM L-glutamine and 20%
FBS. Medium was exchanged by sedimenting the EBs after
2 days and after 4 days the EBs were plated in 20% FBS/
alpha-MEM on tissue culture plasticware which had been
coated overnight at 37 °C with 0.1% gelatin in dH2O. Culture
medium was exchanged every 2–3 days.
Karyotype and genotyping analysis
Performed by Cell Line Genetics, Madison, Wisconsin, USA.
Nucleic acid extractions
Genomic DNA was extracted using the Wizard Genomic DNA
Purification Kit (Promega) according to the manufacturer's
instructions.
Total RNA was extracted using a modification of the
basic Trizol (Life Technologies) protocol. Briefly, 1 ml of
Trizol was added to the sedimented colonies or EBs and
triturated to dissociate the cells. At this point the lysates
were stored at −80 °C until all samples for that cell line
were collected. Upon thaw, lysates were incubated at room
temperature for 10 min, mixed with 200 μl chloroform and
centrifuged in a Phase-Lock Gel (Heavy) Eppendorf tube
(Qiagen). RNA was precipitated from the aqueous phase by
the addition of 250 μl of isopropanol and 250 μl of a high salt
buffer (0.8 M sodium citrate and 1.2 M NaCl) followed by
centrifugation. The RNA pellet was washed twice with 75%
ethanol, dried and resuspended in nuclease-free water. RNA
was DNase treated for 20 min and the DNAse removed using
Ambion's DNA-Free kit. Concentration was determined using
a NanoDrop ND-1000 UV–VIS Spectrophotometer.
PCR analysis of genomic DNA
PCR amplification of the viral sequences (WPRE) and GAPDH
housekeeping gene was performed essentially according to
the Millipore StemCCA instructions using AmpliTaq DNA
Polymerase and GeneAmp dNTPs (Life Technologies). Custom
primers were obtained from Invitrogen and 200 ng of genomic
DNA was amplified using a GeneAmp 9600 according to the
parameters: initial denaturation at 95 °C for 2 min, 30 cycles
of 95 °C for 30 s, 65 °C for 45 s, 72 °C for 45 s followed by a
10 min extension at 72 °C. Products were visualized on a 2%
agarose gel by standard gel electrophoresis.
Gene expression microarray and statistical analysis
of data
Global gene expression microarray was performed and
analyzed using Agilent software, reagents and human One
Color Gene Expression Oligo arrays according to the
manufacturer's instructions. The statistical programming
language R (http://cran.r-project.org/) was used. Raw
expression measurements for all gene probes for all samples
were log (base = 2) transformed then quantile normalized.Quality of data was assured via sample-level inspection by
Tukey box plot, covariance-based PCA scatter plot and
correlation-based Heat Map. Raw expression measurements
for samples deemed outliers were discarded and quantile
normalization repeated. Gene probes not having at least one
expression measurement greater than system noise post
normalization were deemed “noise-biased” and discarded.
System noise was defined as the lowest observed expression
value at which the LOWESS (locally weighted scatterplot
smoothing) fit of the data (CV ~ mean) for each class of samples
(i.e., “hESC_undiff”, “hESC EB_ecto”, “hESC EB_mesend”,
“hiPSC_undiff”, “hiPSC EB_ecto”, “hiPSC EB_mesend”) grossly
deviates from linearity. For gene probes not discarded,
expression measurements were floored to equal system noise
if less than system noise then subject to ANOVA (analysis of
variance) testing under BH (Benjamini and Hochberg) FDR
(false discovery rate) MCC (multiple comparison correc-
tion) condition. Gene probes found to have a corrected
P-value b 0.05 were deemed “potentially informative”
and subject to the Tukey HSD (honestly significant differ-
ence) post-hoc test. Gene probes having a post-hoc
P-value b 0.05 and a difference of class means ≥ 1.50 were
deemed to have expression “significantly different” between
the two classes. Annotation of these gene probes was
accomplished using IPA (Ingenuity, Inc.).
Methylation microarray and data analysis
Bisulfite conversion and array hybridization for methyla-
tion analysis was performed by MD Anderson Cancer Center,
TX. Available average beta values were downloaded from
NCBI GEO (http://www.ncbi.nlm.nih.gov/geo/query/acc.
cgi?acc=GSE34869) and compared at the sample-level using
Pearson correlation.
All microarray and methylation array data may be accessed
through the NCBI GEO public database (Superseries number
GSE51748).
Results
Derivation and characterization of H1-derived NPCs
A population of expandable neuronal precursor cells (NPCs)
were derived from the human embryonic stem cell line, H1
(WA01) as previously described (Kozhich et al., 2012). This
cell line, designated H1.NPC, was negative for the hESC
markers, SSEA4 and Tra-1-60 and positive for the neuronal
marker, NCAM (Fig. 1A) by FACS analysis. Immunostaining
showed the cells to be positive for nestin and TuJ1 indicating a
mixed population of neural stem cells and neurons (Supple-
mentary Fig. 1). At p2, H1.NPCs were subjected to negative
magnetic sorting using Tra-1-60 antibody to remove any
remaining pluripotent cells.
Reprogramming-iPSC characterization
At p5, H1.NPCs were reprogrammed using the Millipore
StemCCA lentiviral kit and plated out on MEF feeders in hESC
medium. A total of 24 colonies were individually isolated
directly from the feeder well and expanded on feeders.
Figure 1 Characterization of the intermediate neural precursor (NPC) population and iPSCs. A and B) FACS analysis, represented by
density plots of fluorescence intensity vs. forward scatter; A) Analysis of the intermediate neural precursor line, H1.NPC, shows the cells to
be negative for the pluripotent stem cell markers, SSEA4 and Tra-1-60, and positive for the neural marker, polysialic neural cell adhesion
molecule (NCAM). B) Analysis of the induced pluripotent stem cell line, H1.NPC-i3, shows the cells to be positive for SSEA4 and Tra-1-60 and
negative for NCAM. C) Gene expressionmicroarray analysis of NANOG, OCT4, SOX2 and TERT in H1 cells and derivatives showing similar levels
of expression (log2 transformed quantile normalized) in both hESCs and hiPSCs. Embryonic stem cell samples are shown in green and iPSCs in
yellow.
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Figure 2 In vitro pluripotency assays for iPSC line, H1.NPC-i3. A & B) Endoderm differentiation — A) Directed differentiation
generates cells positive for the hepatocyte markers, albumin (green) and HNF4α (red) as well as for alpha-fetoprotein (AFP) in B).
C) Ectoderm differentiation — Neurons derived from H1.NPC-i3 are immunopositive for TuJ1 (green) with many MAP-2 positive cells
(red). D) Mesoderm differentiation—cardiomyocytes are immunopositive for myosin heavy chain (green) and Troponin T (red). Note:
Beating cardiomyocytes, indicative of mesoderm differentiation can also be viewed in Supplementary Video 1. Scale bar = 100 μm.
381Comparing molecular profiles of human embryonic and induced pluripotent stem cellsRemaining colonies were collected by collagenase digestion
and replated on Matrigel. From this plate a further 12 colonies
were individually isolated and expanded on Matrigel. Of these
isolated colonies, 3 fromeach culture conditionwere analyzed by
FACS for SSEA4, Tra-1-60 and NCAM. All cell lines were found to
express SSEA4 and Tra-1-60, were immunonegative for SSEA1 and
NCAM, as determinedby FACS analysis, andwere immunopositive
for Oct4 (Fig. 1B and Supplementary Fig. 2). The three
feeder-based iPSC lines, designated H1.NPC-i1, -i2 and -i3,
were confirmed by STR analysis to have an identical genetic
profile to the parent H1 line and had a normal karyotype at p14,
p16 and p18 respectively (Supplementary Fig. 3). Each of these
lines also exhibited a PCR product indicative of the presence of
reprogramming viral sequences not present in the parent lines or
neural precursor intermediate (Supplemental Fig. 4). By gene
expression microarray analysis, the iPSC lines were shown to
express the pluripotency genes, NANOG and OCT4, as well as
telomere reverse transcriptase (TERT), at similar levels to hESC
(Fig. 1C). These levels were reduced in the NPC population.
SOX2, which is also present in neural precursors, is highly
expressed in all cells (Fig. 1C). Two lines, H1.NPC-i1 and
H1.NPC-i3, were tested for in vitro differentiation potential
and were successfully directed to differentiate into cells
representative of the 3 germ lineages. This is represented by
Fig. 2 showing data for H1.NPC-i3 differentiation. Endoderm
differentiation is demonstrated by immunoreactivity to AFP
(Fig. 2A) as well as to HNF4α and albumin (Fig. 2B; hepato-
cytes), ectoderm differentiation by nestin and TuJ1 immuno-
reactivity (Fig. 2C; neurons) and mesoderm differentiation bymyosin heavy chainβ and troponin T immunoreactivity (Fig. 2D;
cardiomyocytes) as well as by patches of spontaneously beating
cells (Supplementary Video 1).Gene expression and methylation profiles of isogenic
samples
Since our original gene expression database, StemCellDB, was
established using MEF-based cultures (Mallon et al., 2013) we
chose the 3 iPSC lines derived on MEFs for further analysis.
Samples were taken from each line for RNA extraction,
gDNA extraction, FACS analysis and embryoid body forma-
tion in 2 media that had been shown to direct cells toward
a mesendodermal lineage (EB_mesend) or an ectodermal
lineage (EB_ecto). After 8 days in culture total RNA was
extracted from the embryoid bodies. RNA from all undiffer-
entiated and differentiated cells, including H1 hESCs, were
analyzed by Agilent One-color microarray. Bioinformatics
analysis revealed no major difference in global gene expres-
sion pattern between the hESC and hiPSC populations under
any culture condition (Figs. 3A, C and E). Notably, analysis of
the undifferentiated samples indicates that there appears
to be more variability between individual samples than
between the two populations (Figs. 3B, D and F). However,
using a 1.5-fold threshold, 625 gene probes were found to be
statistically differentially expressed between the undifferenti-
ated populations (Supplementary Table 1). This was the lowest
number of differentially expressed probes found between any
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reflecting the high overall similarity of the populations. The
number of called probes drops to 260 when a 2-fold threshold is
used. In addition, testing of the undifferentiated sample classes
directly using the Welch-modified t-test under corrected
conditions identifies no gene as being differentially expressed
between hESC and iPSC when a fold-difference magnitude of 2
is used. Upon examination ofmany of the genes described in theprevious study as being differentially expressed between
isogenic hESCs and hiPSCs (Teichroeb et al., 2011), we found
no significant difference in expression in our isogenic samples
(Supplementary Fig. 5). However, many of these genes were
found to be variably expressed in the undifferentiated state or
upon differentiation, which may contribute to the observation
of differences in the nominally undifferentiated state depend-
ing on the quality of the culture.
Table 1 Cross-sample Comparison of Methylation Patterns.
The pair-wise comparison of 27,578 average beta values using Pearson correlation is depicted. Values represented in the table are
the resulting correlation coefficients (Pearson's R) and have been shaded to reflect pair-wise relationships with perfect positive
relationships between samples (Pearson R = 1.00) color-coded dark orange. R values less than perfect are colored lighter orange
with lowest correlations not colored.
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H1 p52 1.00
H1 p56 1.00 1.00
H1.NPC p13 0.93 0.92 1.00
H1.NPC-i1 p9 0.99 0.99 0.93 1.00
H1.NPC-i1 p13 0.99 0.99 0.93 0.99 1.00
H1.NPC-i2 p9 0.99 0.99 0.93 0.99 0.99 1.00
H1.NPC-i2 p15 0.98 0.99 0.92 0.98 0.99 0.99 1.00
H1.NPC-i3 p11 0.98 0.98 0.93 0.99 0.99 0.99 0.98 1.00
H1.NPC-i3 p17 0.99 0.99 0.93 0.99 0.99 0.99 0.98 1.00 1.00
383Comparing molecular profiles of human embryonic and induced pluripotent stem cellsThe methylation profiles of undifferentiated H1 ESC and
iPSC lines as well as H1.NPC were analyzed by bisulfate
conversion and array hybridization. We found that the
pluripotent cell populations exhibited 98–99% accordance
with each other but only 92–93% accordance with the NPC
population (Table 1).
All microarray and methylation array datamay be accessed
through the NCBI GEO public database (Superseries number
GSE51748).Regulation of NNAT by methylation
In the previous isogenic H9 hESC vs. hiPSC study, the
only gene that showed significant variation was neonatin
(Teichroeb et al., 2011). In contrast, NNAT does not meet
the criteria for significantly different gene expression levels
between the isogenic H1 hESCs and their hiPSC derivatives
(Fig. 4A). However, upon examination of StemCellDB it is
clear that NNAT expression varies considerably within
both hESC and hiPSC populations (Fig. 4B). We correlated
methylation to gene expression levels in the StemCellDB
samples and confirm that gene expression is reduced with
increasing methylation as previously described. Interestingly,
in StemCellDB, it appears that the effect of methylation on
gene expression levels is muchmore profound in hiPSCs than in
the hESCs where the average r2 values for all methylation
probes are 0.961 and 0.766 respectively (Figs. 4C and D).Figure 3 Gene expression array analysis. For all panels, log2 transform
gene probes, representing all probes expressed above noise, were use
legend. H1 ESC undiff— green; H1.NPC iPSC undiff— yellow; H1 ESC EB_
blue; H1.NPC iPSC EB_mesend — cyan. (A & B) Covariance PCA Scatter
describes the percent total variance explained by the first principal co
explained by the second principal component (2.8%). B) 7 undifferen
explained by the first principal component (98.4%). The y-axis descri
component (0.8%). (C & D) Pearson Correlation Heat Map. C) Map depic
undifferentiated samples. (E & F) Hierarchical Cluster Dendrogram. E) D
F) Dendrogram depicts 7 undifferentiated samples. For all images, the
project.org/).However, although there is some variability in gene expression
and methylation levels in the current isogenic H1 hiPSC
samples, the correlation is not striking. In addition, with only
2 samples, it is not statistically relevant to obtain an r2 value
for the H1 hESCs.
Discussion
Although the molecular profiles of many isogenic cells have
been compared, these studies mostly refer to differentiated
cells, such as blood cells, used to derive iPSCs, which have
been subsequently differentiated back into blood (Kim
et al., 2010). The first comparison of isogenic pluripotent
cells was conducted with the female H9 hESC line and
indicated that there was significant variation between hESCs
and hiPSCs in the expression of neonatin—NNAT (Teichroeb
et al., 2011). This group also found much clonal variation in
the expression of several imprinted genes and concluded
that reprogramming can lead to dysregulation of genomic
imprinting. In contrast, we find no significant difference in the
expression ofNNAT in the current samples derived from the H1
hESC line. However, examination of our publicly available
database, StemCellDB (Mallon et al., 2013), shows that NNAT
is variably expressed in 21 genetically unique hESCs and 8
hiPSCs. As demonstrated by Teichroeb et al, gene expression
of NNAT is modulated by methylation in these samples but,
interestingly, it may be that hiPSCs are more sensitive to thised quantile normalized Agilent expression values for a set of 38,449
d. Color-coding is uniform across all panels and is explained in the
ecto— red; H1.NPC iPSC EB_ecto—magenta; H1 ESC EB_mesend—
plot. A) 21 undifferentiated and differentiated samples. The x-axis
mponent (94.6%). The y-axis describes the percent total variance
tiated samples. The x-axis describes the percent total variance
bes the percent total variance explained by the second principal
ts 21 undifferentiated and differentiated samples. D) Map depicts 7
endrogram depicts 21 undifferentiated and differentiated samples.
statistical programming language R was used (www.http://www.r-
Figure 4 Regulation of NNAT gene expression. A) NNAT gene expression in H1 and derivatives shows little variation in isogenic
pluripotent stem cell populations. B) NNAT gene expression in 21 genetically unique hESC and 8 hiPSC lines (StemCellDB) showing
variability in expression levels. For both A) and B), undifferentiated hESCs are shown in green and hiPSCs in yellow. (C and D) Gene
expression of NNAT in StemCellDB samples is reduced with increasing methylation but the decrease in expression is more profound in
hiPSCs (C) than in hESCs (D). E) Isogenic H1 hiPSCs show little effect of methylation.
384 B.S. Mallon et al.regulation. In many cases, gene expression varies as a function
of differentiation and so variable expression of genes described
by Teichroeb et al. (2011) and others may well be due to
alteration of culture conditions during reprogramming and in
routine maintenance of the cells (Newman and Cooper, 2010;
Wutz, 2012).In this study, we find few gene expression differences
in any undifferentiated or differentiated condition in accor-
dance with our previous findings (Mallon et al., 2013). We also
find no global differences in the methylation profile of the
pluripotent populations. Although our findings on isogenic
cells varied from that of Teichroeb et al., it could be that XCI
385Comparing molecular profiles of human embryonic and induced pluripotent stem cellseffects are responsible for the variations observed in the
female, H9, derivatives which are not apparent in themale, H1,
derivatives. Interestingly, although we did not find variation in
NNAT expression in our isogenic lines, we did find variability in a
larger population of cells which was inversely correlated with
methylation. This correlation was more profound in hiPSCs than
in hESCs perhaps suggesting that hiPSCs have a more open
genomic conformation or that NNAT is exclusively regulated by
methylation in the iPSCs whereas other elements can influence
its expression in the hESCs. However, this profound correlation
was not observed in the current hiPSC samples suggesting that
this regulation is either genome-specific or is possibly related
to the method of reprogramming. The original samples were
reprogrammedwith individual retroviruses whereas the current
samples were reprogrammed using a polycistronic lentivirus.
Further studies should be able to clarify this point.
Both gene expression and methylation analyses revealed
differences between the pluripotent cells and the intermedi-
ate NPCs. However, it would appear that epigeneticmemory is
not grossly apparent in the hiPSC lines at themethylation level
at the passages tested. Since some of these passages are
relatively early (p9) this may contrast with previous studies
(Kim et al., 2010) but it should be emphasized that the
differentiated cell population used in this study was derived
from pluripotent cells and not tissue. Therefore, it is possible
that not all epigeneticmarks of the pluripotent state had been
erased in the intermediate population. There appears to be
mounting evidence, however, that epigenetic changes ob-
served between hESCs and hiPSCs may be due in large part to
culture conditions (Newman and Cooper, 2010; Wutz, 2012).
This could include not only the local culture maintenance
protocols, but the vector(s) used as well as the manner of
reprogramming itself. Further studies of this type should help
to elucidate and understand themechanism of such epigenetic
drift. In conclusion, our findings show that reprogramming
itself does not inherently affect the genetic or epigenetic
profile of the cells which is important aswemove iPSCs toward
drug development or therapeutic application.
Supplementary data to this article can be found online at
http://dx.doi.org/10.1016/j.scr.2013.11.010.
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